Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

New study maps bacterial communication to fight MRSA infections

Imagine two people talking over a walkie-talkie set. Successful communication depends on them being tuned to the same frequency.

16 Jul 2025

FINRISK population-based study investigates factors associated with prevalence of antibiotic resistance

A population-based study led by the University of Turku, Finland, investigated factors associated with the prevalence of antibiotic resistance.

16 Jul 2025

University of Zurich develops molecules to rapidly detect dangerous bacteria

Rapidly identifying certain bacteria allows antibiotic treatments to be optimised. A team from the University of Zurich, supported by the SNSF, has developed molecules to detect and capture certain species.

16 Jul 2025

Staph bacterium possesses a surprising level of metabolic redundancy, study reveals

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we target deadly pathogens like staph infections.

16 Jul 2025

Routine vaccines may be the key to fighting antibiotic resistance

A study reveals that rising vaccine coverage in children is linked to reduced antibiotic prescriptions, suggesting a shift in the fight against drug resistance.

16 Jul 2025

Hungry bacteria choose food over danger in the human gut

Bacteria that cause intestinal infections typically avoid a stinky chemical - one that can kill them at high enough concentrations - inside human intestines, but they may actually swim toward it when a hearty meal is the reward.

16 Jul 2025

Senegal becomes ninth African country to eliminate trachoma

The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO's African Region to have achieved this feat.

15 Jul 2025

Early antibiotic exposure weakens infant immune development

A new study led by researchers at the University of Rochester Medical Center (URMC) found that early-life exposure to antibiotics can impair an infant's developing immune system, and that a naturally occurring metabolite may hold the key to reversing that damage.

14 Jul 2025

Dynamic mapping exposes hidden dynamics of gut microbiome

This study reveals how gut microbiome interactions influence E. coli colonization, using Dynamic Covariance Mapping to analyze community dynamics and stability.

14 Jul 2025

Burundi eliminates trachoma and sets example for disease control in Africa

The World Health Organization (WHO) has validated Burundi as having eliminated trachoma as a public health problem, making it the eighth country in WHO's African Region to reach this important milestone.

11 Jul 2025

TMP-SMX in early pregnancy increases risk of birth defects, new study shows

A large US cohort study found that using trimethoprim-sulfamethoxazole (TMP-SMX) for UTI in the first trimester of pregnancy was associated with a higher risk of congenital malformations compared to β-lactam antibiotics. No increased risk was seen with nitrofurantoin or fluoroquinolones.

10 Jul 2025

Natural compounds from turmeric and rhubarb show promise against superbugs in wastewater

When we're taking antibiotics, some of the dose is excreted with urine and feces and ends up in our wastewater. The presence of this low dose of antibiotic creates an opportunity for resistant bacteria to evolve.

10 Jul 2025

AlphaFold2 enables large scale analysis of enzyme evolution

Enzymes catalyze chemical reactions in organisms - without which life would not be possible. Leveraging AlphaFold2 artificial intelligence, researchers at Charité – Universitätsmedizin Berlin have now succeeded in analyzing the laws of their evolution on a large scale.

10 Jul 2025

Australian scientists use AI to create protein that kills superbugs

In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer. What would normally take decades for a scientist to create – a custom-made protein for a particular disease – can now be done in seconds.

9 Jul 2025

New TB drugs show promise with fewer side effects than linezolid

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in the treatment of drug-resistant TB.

8 Jul 2025

Oral lysozyme can restore healthy gut balance and reverse signs of vascular aging

A study reveals that lysozyme (LYZ) plays a pivotal role in age-related blood vessel inflammation by influencing gut bacteria.

8 Jul 2025

Synthetic Biology and the Pursuit of Living Diagnostics and Therapeutics

In this interview, Professor James J. Collins, founder of the field of Synthetic Biology, discusses his journey to founding the field of synthetic biology and the potential of living diagnostics.

From Pittcon 7 Jul 2025

Research highlights an increase in informal use of doxyPEP/PrEP among key populations in the Netherlands

New research analyzing an online survey of 1,633 respondents found 15% recent use of doxycycline post- and pre-exposure prophylaxis (doxyPEP/PrEP) among men who have sex with men (MSM), transgender and gender diverse people in the Netherlands according to a recent study published by Eurosurveillance.

4 Jul 2025

New study moves closer to defeating dormant tuberculosis cells

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports.

4 Jul 2025

Vaginal microbiome fights back against stubborn BV infections

Vaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for personalized approaches to enhance efficacy.

3 Jul 2025